Allergic contact dermatitis by ophthalmological medications in Brazil: experience of a dermatology departmentY. K. Chan email@example.com, E. S. Novalo Goto, R. Fachini Jardim Criado, P. R. CriadoShow more: Authors information and Publication history
Department of Dermatology, Faculdade de Medicina do ABC, Santo André, São Paulo, BrazilHistory
Published online: 15 March 2021
Accepted: 26 January 2021
Received: 11 September 2020
Topical treatments in ophthalmologic therapy are significant for the developmentof allergic contact dermatitis (ACD) in the periorbital region. Preservatives, antibiotics,glucocorticoids, and beta-blocker eye drops are defined as drugs with thehighest sensitizing potential. The unavailability of patch test batteries containingsubstances of ophthalmological use makes it difficult for this diagnosis. In thepresent report, we describe six patients who developed ACD induced by differentagents presenting in eye drops, confirmed with the cutaneous patch tests. TheACD diagnosis due to ophthalmic medications can be challenging, since manydifferent agents can cause it, and the sensitivity of these cutaneous tests is low.Thus, early diagnosis is essential to avoid the complications of ACD on the skinand ocular disorders related to chronic periorbital eczema.Key words
Allergic contact dermatitis; eye drops; patch test; blepharoconjunctivitis; ophtalmic medications.
Cite this article as:
Chan YK, Novalo Goto ES, Fachini Jardim Criado R, Criado PR. Allergic contact dermatitis by ophthalmological medications in Brazil: experience of a dermatology department. Eur Ann Allergy Clin Immunol 2021;53(6):280-3. doi:10.23822/EurAnnACI.1764-1489.190.